Skip to main content
. 2019 Oct 26;2(4):83. doi: 10.3390/mps2040083

Figure A2.

Figure A2

Controls for BNP signal thresholding. In order to categorize signal intensities of cardiomyocytes expressing BNP, endothelin-1 treatment can be used to determine high-intensity threshold as it maximises BNP expression relative to untreated cells, whereas bosentan treatment has the opposite effect (defining low/nonexistent signal). Scale bar = 100 μm.